David Eckerdal
1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Appropriate randomization, adherence to Ethics board approved trial protocol and transparent reporting of amendments and exclusions define RCT integrity
Eckerdal, David LU ; Pakosta, Hendrik ; Ali, Muhanned LU
and Atroshi, Isam
LU
(2025)
In EFORT Open Reviews
10(7).
p.572-573
- Contribution to journal › Letter
- 2024
-
Mark
Dupuytren Disease : Treatment effect durability, recurrence, and patient-reported outcome measures
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Development of a new patient-reported outcome measure for Dupuytren disease : A study protocol
- Contribution to journal › Article
-
Mark
Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease : a systematic review
Eckerdal, David LU ; Pakosta, Hendrik ; Ali, Muhanned LU
and Atroshi, Isam
LU
(2024)
In EFORT Open Reviews
9(7).
p.625-631
- Contribution to journal › Article
- 2023
-
Mark
Responsiveness of the patient-specific Canadian occupational performance measure and a fixed-items activity limitations measure in patients with dupuytren disease
- Contribution to journal › Article
-
Mark
Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease : A Prospective Cohort Study
- Contribution to journal › Article
- 2022
-
Mark
Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease : A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy
- Contribution to journal › Article